Comment on ‘Histopathologic evaluation of liver metastases from colorectal cancer in patients treated with FOLFOXIRI plus bevacizumab'

por Bibeau, F, Gil, H, Castan, F, Boissière-Michot, F
Publicado 2013

The RENAPE observational registry: rationale and framework of the rare peritoneal tumors French patient registry

por Villeneuve, L., Passot, G., Glehen, O., Isaac, S., Bibeau, F., Rousset, P., Gilly, F. N.
Publicado 2017

Proteomic analysis of RCL2 paraffin-embedded tissues

por Bellet, V, Boissière, F, Bibeau, F, Desmetz, C, Berthe, M L, Rochaix, P, Maudelonde, T, Mangè, A, Solassol, J
Publicado 2008

p53 status and response to radiotherapy in rectal cancer: a prospective multilevel analysis

por Lopez-Crapez, E, Bibeau, F, Thézenas, S, Ychou, M, Simony-Lafontaine, J, Thirion, A, Azria, D, Grenier, J, Senesse, P
Publicado 2005

Genetic profiling of chromosome 1 in breast cancer: mapping of regions of gains and losses and identification of candidate genes on 1q

por Orsetti, B, Nugoli, M, Cervera, N, Lasorsa, L, Chuchana, P, Rougé, C, Ursule, L, Nguyen, C, Bibeau, F, Rodriguez, C, Theillet, C
Publicado 2006

Increased expression of class III β-tubulin in castration-resistant human prostate cancer

por Terry, S, Ploussard, G, Allory, Y, Nicolaiew, N, Boissière-Michot, F, Maillé, P, Kheuang, L, Coppolani, E, Ali, A, Bibeau, F, Culine, S, Buttyan, R, de la Taille, A, Vacherot, F
Publicado 2009

TP53 mutations predict disease control in metastatic colorectal cancer treated with cetuximab-based chemotherapy

por Oden-Gangloff, A, Di Fiore, F, Bibeau, F, Lamy, A, Bougeard, G, Charbonnier, F, Blanchard, F, Tougeron, D, Ychou, M, Boissière, F, Le Pessot, F, Sabourin, J-C, Tuech, J-J, Michel, P, Frebourg, T
Publicado 2009

Antibody targeting of claudin-1 as a potential colorectal cancer therapy

por Cherradi, S., Ayrolles-Torro, A., Vezzo-Vié, N., Gueguinou, N., Denis, V., Combes, E., Boissière, F., Busson, M., Canterel-Thouennon, L., Mollevi, C., Pugnière, M., Bibeau, F., Ychou, M., Martineau, P., Gongora, C., Del Rio, M.
Publicado 2017

Sorafenib and irinotecan (NEXIRI) as second- or later-line treatment for patients with metastatic colorectal cancer and KRAS-mutated tumours: a multicentre Phase I/II trial

por Samalin, E, Bouché, O, Thézenas, S, Francois, E, Adenis, A, Bennouna, J, Taieb, J, Desseigne, F, Seitz, J F, Conroy, T, Galais, M P, Assenat, E, Crapez, E, Poujol, S, Bibeau, F, Boissière, F, Laurent-Puig, P, Ychou, M, Mazard, T
Publicado 2014

A refined molecular taxonomy of breast cancer

por Guedj, M, Marisa, L, de Reynies, A, Orsetti, B, Schiappa, R, Bibeau, F, MacGrogan, G, Lerebours, F, Finetti, P, Longy, M, Bertheau, P, Bertrand, F, Bonnet, F, Martin, A L, Feugeas, J P, Bièche, I, Lehmann-Che, J, Lidereau, R, Birnbaum, D, Bertucci, F, de Thé, H, Theillet, C
Publicado 2012

Clinical and molecular practice of European thoracic pathology laboratories during the COVID-19 pandemic. The past and the near future

por Hofman, P., Ilié, M., Chamorey, E., Brest, P., Schiappa, R., Nakache, V., Antoine, M., Barberis, M., Begueret, H., Bibeau, F., Bonnetaud, C., Boström, P., Brousset, P., Bubendorf, L., Carvalho, L., Cathomas, G., Cazes, A., Chalabreysse, L., Chenard, M.-P., Copin, M.-C., Côté, J.-F., Damotte, D., de Leval, L., Delongova, P., Thomas de Montpreville, V., de Muret, A., Dema, A., Dietmaier, W., Evert, M., Fabre, A., Forest, F., Foulet, A., Garcia, S., Garcia-Martos, M., Gibault, L., Gorkiewicz, G., Jonigk, D., Gosney, J., Hofman, A., Kern, I., Kerr, K., Kossai, M., Kriegsmann, M., Lassalle, S., Long-Mira, E., Lupo, A., Mamilos, A., Matěj, R., Meilleroux, J., Ortiz-Villalón, C., Panico, L., Panizo, A., Papotti, M., Pauwels, P., Pelosi, G., Penault-Llorca, F., Pop, O., Poté, N., Cajal, S.R.Y., Sabourin, J.-C., Salmon, I., Sajin, M., Savic-Prince, S., Schildhaus, H.-U., Schirmacher, P., Serre, I., Shaw, E., Sizaret, D., Stenzinger, A., Stojsic, J., Thunnissen, E., Timens, W., Troncone, G., Werlein, C., Wolff, H., Berthet, J.-P., Benzaquen, J., Marquette, C.-H., Hofman, V., Calabrese, F.
Publicado 2020